
Heska Corporation HSKA
Quartalsbericht 2023-Q1
hinzugefügt 23.05.2026
Heska Corporation DPO 2011-2026 | HSKA
DPO Jährlich Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.7 | 37.6 | 34.2 | 37.6 | 43.7 | 40.6 | 33.5 | 37.8 | 31.5 | 37.3 | 46.4 | 35.7 | 18.7 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 46.4 | 18.7 | 36.5 |
DPO Vierteljährlich Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37.4 | - | 35.3 | 29.8 | 35.5 | - | 34.7 | 35.8 | 39.2 | - | 33.2 | 31.2 | 36.4 | - | 33.4 | 43.7 | 40.9 | - | 32.7 | 36.5 | 36.9 | - | 45.4 | 30.8 | 31.9 | - | 27.9 | 31.6 | 39.4 | - | 42.3 | 51.1 | 44.6 | - | 33.1 | 32.3 | 34.1 | - | 39.8 | 30.6 | 39.8 | - | 47.5 | 47.3 | 41.4 | - | 33.9 | 36.6 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 51.1 | 27.9 | 37 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
35.2 | $ 19.5 | 7.5 % | $ 600 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 5.76 | 11.41 % | $ 7.66 M | ||
|
Castle Biosciences
CSTL
|
65.8 | $ 21.6 | 5.93 % | $ 626 M | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
196 | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
48.6 | $ 133.06 | 4.75 % | $ 16.7 B | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
ICON Public Limited Company
ICLR
|
11 | $ 152.8 | 6.18 % | $ 12 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 23.12 | 3.63 % | $ 1.23 B | ||
|
Illumina
ILMN
|
57.1 | $ 168.06 | -1.68 % | $ 26 B | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Interpace Biosciences
IDXG
|
33 | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Mettler-Toledo International
MTD
|
53.4 | - | - | $ 24.3 B | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
23.6 | - | - | $ 6.94 B | ||
|
NeoGenomics
NEO
|
19.7 | $ 11.31 | 11.54 % | $ 1.45 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 185.79 | 3.29 % | $ 9.21 B | ||
|
Natera
NTRA
|
17.9 | $ 222.1 | 4.84 % | $ 30.4 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 458.69 | 1.75 % | $ 13.2 B | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
10.1 | $ 19.75 | 3.73 % | $ 442 M | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 4.69 | 6.59 % | $ 434 M | ||
|
Personalis
PSNL
|
65.7 | $ 12.1 | 12.24 % | $ 1.08 B | ||
|
Senseonics Holdings
SENS
|
68 | $ 7.01 | 4.32 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
1.44 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
32.4 | - | - | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 260.97 | 0.79 % | $ 21.7 B | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | - | - | $ 4.42 B | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 482.03 | 1.7 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.68 | -2.4 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.12 | 3.52 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 196.12 | 1.27 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
102 | $ 376.47 | -0.87 % | $ 22.4 B |